The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: Interim policy guidance

by Christian Lienhardt, Karin Weyer, Dennis Falzon et al.
World Health Organization, 2013

64 pp. 722 kB:
http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf

WHO Member States have requested the organization to provide interim policy guidance on the use of bedaquiline as part of the treatment of multidrug-resistant tuberculosis (MDR-TB). This document provides interim guidance for the use of bedaquiline in conjunction with other WHO-recommended MDR-TB treatments. It also specifies the essential treatment and management conditions for the use of this drug.

(Visited 10 times, 1 visits today)
This entry was posted in Essential Medicines, General, Tuberculosis. Bookmark the permalink.